OM Outset Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: OM

Price (delayed)

$3.75

Market cap

$193.96M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.37

Enterprise value

$360.96M

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to ...

Highlights
OM's gross profit has surged by 55% year-on-year and by 6% since the previous quarter
OM's gross margin is up by 46% year-on-year and by 11% since the previous quarter
OM's quick ratio is up by 21% since the previous quarter but it is down by 19% year-on-year
Outset Medical's revenue has increased by 6% YoY but it has decreased by 4.1% from the previous quarter
OM's debt has soared by 96% YoY and by 49% from the previous quarter
The equity has plunged by 57% YoY and by 24% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://outsetmedical.com
Peers: OBIO

Key stats

What are the main financial stats of OM
Market
Shares outstanding
51.72M
Market cap
$193.96M
Enterprise value
$360.96M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.03
Price to sales (P/S)
1.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.89
Earnings
Revenue
$125.08M
EBIT
-$152.58M
EBITDA
-$145.37M
Free cash flow
-$135.51M
Per share
EPS
-$3.37
Free cash flow per share
-$2.66
Book value per share
$1.85
Revenue per share
$2.46
TBVPS
$6.8
Balance sheet
Total assets
$346.24M
Total liabilities
$253.04M
Debt
$202.51M
Equity
$93.2M
Working capital
$274.72M
Liquidity
Debt to equity
2.17
Current ratio
6.42
Quick ratio
5.26
Net debt/EBITDA
-1.15
Margins
EBITDA margin
-116.2%
Gross margin
24.6%
Net margin
-134.9%
Operating margin
-130.5%
Efficiency
Return on assets
-51.8%
Return on equity
-122.5%
Return on invested capital
-42%
Return on capital employed
-51.6%
Return on sales
-122%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

OM stock price

How has the Outset Medical stock price performed over time
Intraday
1.08%
1 week
-3.1%
1 month
-7.18%
1 year
-80.71%
YTD
-30.68%
QTD
-2.6%

Financial performance

How have Outset Medical's revenue and profit performed over time
Revenue
$125.08M
Gross profit
$30.79M
Operating income
-$163.2M
Net income
-$168.77M
Gross margin
24.6%
Net margin
-134.9%
OM's gross profit has surged by 55% year-on-year and by 6% since the previous quarter
OM's gross margin is up by 46% year-on-year and by 11% since the previous quarter
The operating margin has grown by 8% year-on-year
OM's net margin is up by 6% YoY

Growth

What is Outset Medical's growth rate over time

Valuation

What is Outset Medical stock price valuation
P/E
N/A
P/B
2.03
P/S
1.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.89
OM's EPS is up by 4% year-on-year and by 3.2% since the previous quarter
The equity has plunged by 57% YoY and by 24% from the previous quarter
OM's price to book (P/B) is 37% lower than its last 4 quarters average of 3.2
OM's price to sales (P/S) is 60% lower than its last 4 quarters average of 3.8
Outset Medical's revenue has increased by 6% YoY but it has decreased by 4.1% from the previous quarter

Efficiency

How efficient is Outset Medical business performance
Outset Medical's ROE has plunged by 89% YoY and by 20% from the previous quarter
The return on invested capital has increased by 17% year-on-year and by 10% since the previous quarter
Outset Medical's return on assets has decreased by 16% YoY
OM's return on sales is up by 12% year-on-year

Dividends

What is OM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OM.

Financial health

How did Outset Medical financials performed over time
The total assets is 37% greater than the total liabilities
The total liabilities has soared by 73% year-on-year and by 33% since the previous quarter
The current ratio has increased by 22% since the previous quarter but it has declined by 16% year-on-year
OM's debt is 117% more than its equity
OM's debt has soared by 96% YoY and by 49% from the previous quarter
The debt to equity has surged by 95% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.